Re: NASH
Given the comments on the call and the evolution of the NASH program, I am confident that desired liver fat reductions are being found at lower doses.
the real question: will this fat reduction yield indications of fibrosis reduction? Many experts think it should, but of course, this is biotech.
I have some new thoughts about the AIWG trial results but need to mull it over.
I am still hospitalized and must remain for awhile. It was a close call (Biotech Boss has my permission to disclose details). i must relearn standing and walking.
BUT, the first marrow biopsy revealed an improbable result. It is free of cancer and gene markers. The donor cells have already begun to re-architect the marrow and reduce the cancer caused fibrosis.
One day and month at a time. My current treatment is intense and progress is steady. All my best.